Profil
Eric Laub currently works at Jounce Therapeutics, Inc., as Head-Investor & Media Relations from 2021.
Postes actifs de Eric Laub
| Sociétés | Poste | Début |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Investor Relations Contact | 01/09/2021 |
Expériences
Fonctions occupées
Relations
18
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
